Charles River Laboratories 2016 4Q Results and 2017 Guidance

Charles River Laboratories presented 4Q 2016 results and 2017 financial guidance on February 14, 2017. The company highlighted strategic growth investments, portfolio expansion through acquisitions, and efficiency initiatives, while noting that its services supported approximately 70% of FDA-approved drugs in 2016.